Across Global Alliance Adopts Wemedoo's oomnia Platform to Transform Global Clinical Trial Management
核心洞察
Across Global Alliance (搜索) has selected Wemedoo's oomnia (搜索)® as its centralized clinical trial infrastructure, integrating essential functions like EDC, CTMS, RTSM, and eTMF into a unified platform across 90+ countries.
The strategic partnership aims to streamline clinical trial management, enhance real-time collaboration, and ensure regulatory compliance while eliminating inefficiencies from fragmented systems.
The implementation of oomnia (搜索) as the digital backbone will enable alliance members to focus on scientific progress by optimizing trial execution and providing real-time data quality reviews.
In a significant move to revolutionize clinical trial management, Across Global Alliance (搜索) has partnered with Wemedoo AG (搜索) to implement oomnia (搜索)® as its centralized digital infrastructure. The partnership, announced in Singapore, marks a strategic shift in how clinical trials will be conducted across the alliance's network spanning more than 90 countries.
Comprehensive Platform Integration
The selection of oomnia (搜索)® came after an extensive evaluation process, where the platform emerged as the sole solution capable of addressing the alliance's complex operational requirements. The system uniquely integrates critical clinical trial functions - Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF) - into a single, cohesive platform.
"Running global clinical trials requires a system that facilitates seamless collaboration, eliminates unnecessary delays, and ensures data consistency across all sites," explained Steven Bukvic, Chairman of the Across Global Alliance (搜索). "With oomnia (搜索), we have found a platform that meets these demands while maintaining compliance and operational flexibility."
Enhanced Operational Efficiency
The unified platform addresses a crucial challenge in clinical research - the inefficiencies created by fragmented systems and disconnected data workflows. By centralizing operations, oomnia (搜索)® enables real-time collaboration among alliance members, streamlines data management processes, and maintains consistent quality standards across all trial sites.
Nina Cihoric, CEO of Wemedoo AG (搜索), emphasized the transformative potential of the partnership: "This partnership with Across Global Alliance (搜索) is another step toward transforming how clinical trials are managed. By providing a truly integrated and adaptive system, we enable alliance members to focus on scientific progress rather than administrative complexity."
Impact on Global Clinical Research
The implementation of oomnia (搜索)® as the alliance's digital backbone represents a significant advancement in clinical trial infrastructure. The platform's capabilities extend beyond basic trial management, offering:
- Real-time data quality reviews
- Streamlined regulatory compliance processes
- Enhanced collaboration tools for global teams
- Unified operational framework across diverse therapeutic areas
This strategic integration positions Across Global Alliance (搜索) to deliver more efficient, cost-effective clinical research services while maintaining the highest standards of data integrity and regulatory compliance.